Proton Beam for Cancer: 34.2% of denials overturned
In 307 California IMR decisions from 2005 to 2025, reviewers overturned 105 (34.2%). In the last five years: 51.3% of 156. 192 were medical-necessity disputes, 115 experimental/investigational.
By year (last five)
| Year | Decisions | Overturned |
|---|---|---|
| 2021 | 25 | 8.0% |
| 2022 | 29 | 51.7% |
| 2023 | 41 | 56.1% |
| 2024 | 33 | 63.6% |
| 2025 | 28 | 67.9% |
What the findings mention
| What the findings mention | Decisions | Overturned | All decisions here |
|---|---|---|---|
| Published evidence citedThe findings refer to peer-reviewed or published evidence. | 106 | 27.4% | 34.2% |
| Guidelines or criteria citedThe findings cite guidelines, criteria or a standard of care. | 65 | 40.0% | 34.2% |
| Records did not supportThe findings say the documentation did not show what was needed (usually an upheld denial). | 15 | 0.0% | 34.2% |
| Experimental or investigationalThe findings discuss whether the treatment is experimental. | 9 | 22.2% | 34.2% |
| Alternatives contraindicatedThe findings mention a contraindication to the plan's preferred option. | 3 | 33.3% | 34.2% |
| Prior therapies failedThe findings mention treatments that were tried without adequate response. | 3 | 66.7% | 34.2% |
Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.
From recent overturned decisions
“The physician reviewer found that a patient has requested authorization and coverage for proton beam radiation therapy and/or placement of a perirectal hydrogel spacer. Proton beam has unique properties compared to standard photon or X-ray beam in its ability to deposit radiation dose. Oftentimes, fewer proton beams can be utilized to achieve a dose distribution that is similar to standard …”
“The physician reviewer found that a patient has requested authorization and coverage for proton beam radiation therapy (PBRT). PBRT has unique properties compared to standard X-ray or photon therapy in its ability to deposit radiation dose. Oftentimes, fewer proton beams can be utilized to achieve a dose distribution similar to an X-ray beam. This potentially results in less radiation exposure …”
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement for proton beam radiation therapy (PBRT) services. Though cancer patients with leptomeningeal metastasis are generally associated with poor prognosis, a young patient with good performance status may be offered more aggressive therapeutic management. While systemic drug therapy would be the mainstay modality, irradiation to the …”
And one the reviewer upheld
“The physician reviewer found that a patient has requested authorization and coverage for proton beam radiation therapy. The patient was appropriately recommended a course of radiation therapy as a treatment modality for intermediate risk prostate cancer, per National Comprehensive Cancer Network (NCCN) guidelines. Radiation therapy itself is a category 1 standard of care treatment for prostate cancer. However, the utilization …”
- California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
- Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
- Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
- Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
- Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.
Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.
Questions
How often were Proton Beam denials for Cancer overturned?
In 307 California IMR decisions from 2005 to 2025, reviewers overturned 105 (34.2%). In the last five years: 51.3% of 156. 192 were medical-necessity disputes, 115 experimental/investigational.
What should an appeal document, based on these findings?
Whatever the plan's criteria ask for, shown in the record: the treatments already tried and their results, contraindications to the plan's preferred option, the guideline or evidence that supports the request, and the treating clinician's reasoning written to the criteria. The tag table shows which of these the reviewers mentioned most in overturned cases.
Does a California IMR result apply to my plan?
Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but they weigh the same things.
Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.